Add to ORKGCheckpoint inhibitors have been reported to cause varied autoimmune manifestations including autoimmune encephalitis. Here we describe the development of limbic encephalitis in a patient with renal cell carcinoma following treatment with nivolumab and its resolution following corticosteroid therapy
The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become availabl...
Ipilimumab is a monoclonal antibody that enhances the efficacy of the immune system by targeting a c...
Limbic encephalitis is an inflammatory disease of the central nervous system characterized by divers...
Abstract Background Great progress has recently been made in the treatment of metastatic renal cell ...
Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malign...
Abstract Background Immune checkpoint blockade is developed as standard treatment for non-small cell...
Rationale: Paraneoplastic limbic encephalitis (PLE) is one of the most common causes of neurologic p...
Background: With the expanding indications and thus broader use of immune checkpoint inhibitors, cli...
Paraneoplastic limbic encephalitis (PLE) associated with Hu antibodies is a rare autoimmune disorder...
Immune checkpoint inhibitors (ICPis) have revolutionised the treatment of melanoma by significantly ...
Immune checkpoint inhibitors are antibodies, which enhance cellular and humoral immune responses and...
Item does not contain fulltextINTRODUCTION: Immune checkpoint inhibitors have taken an important pla...
Background Despite unprecedented efficacy across multiple tumor types, immune checkpoint inhibitor t...
Recurrent clear cell ovarian carcinoma is a difficult to treat condition and early trial data has su...
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is design...
The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become availabl...
Ipilimumab is a monoclonal antibody that enhances the efficacy of the immune system by targeting a c...
Limbic encephalitis is an inflammatory disease of the central nervous system characterized by divers...
Abstract Background Great progress has recently been made in the treatment of metastatic renal cell ...
Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malign...
Abstract Background Immune checkpoint blockade is developed as standard treatment for non-small cell...
Rationale: Paraneoplastic limbic encephalitis (PLE) is one of the most common causes of neurologic p...
Background: With the expanding indications and thus broader use of immune checkpoint inhibitors, cli...
Paraneoplastic limbic encephalitis (PLE) associated with Hu antibodies is a rare autoimmune disorder...
Immune checkpoint inhibitors (ICPis) have revolutionised the treatment of melanoma by significantly ...
Immune checkpoint inhibitors are antibodies, which enhance cellular and humoral immune responses and...
Item does not contain fulltextINTRODUCTION: Immune checkpoint inhibitors have taken an important pla...
Background Despite unprecedented efficacy across multiple tumor types, immune checkpoint inhibitor t...
Recurrent clear cell ovarian carcinoma is a difficult to treat condition and early trial data has su...
Nivolumab is an immune checkpoint inhibitor that targets programmed death-1 on T cells and is design...
The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become availabl...
Ipilimumab is a monoclonal antibody that enhances the efficacy of the immune system by targeting a c...
Limbic encephalitis is an inflammatory disease of the central nervous system characterized by divers...